WO2008062274A3 - Pharmaceutical formulations of nsaids for parentral use - Google Patents

Pharmaceutical formulations of nsaids for parentral use Download PDF

Info

Publication number
WO2008062274A3
WO2008062274A3 PCT/IB2007/003515 IB2007003515W WO2008062274A3 WO 2008062274 A3 WO2008062274 A3 WO 2008062274A3 IB 2007003515 W IB2007003515 W IB 2007003515W WO 2008062274 A3 WO2008062274 A3 WO 2008062274A3
Authority
WO
WIPO (PCT)
Prior art keywords
nsaids
parentral
pharmaceutical formulations
pharmaceutical composition
stable pharmaceutical
Prior art date
Application number
PCT/IB2007/003515
Other languages
French (fr)
Other versions
WO2008062274A2 (en
Inventor
Indravadan Ambalal Modi
Ashok Omray
Sachin K Salampure
Bakulesh Mafatlal Khamar
Original Assignee
Cadila Pharmaceuticals Ltd
Indravadan Ambalal Modi
Ashok Omray
Sachin K Salampure
Bakulesh Mafatlal Khamar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmaceuticals Ltd, Indravadan Ambalal Modi, Ashok Omray, Sachin K Salampure, Bakulesh Mafatlal Khamar filed Critical Cadila Pharmaceuticals Ltd
Publication of WO2008062274A2 publication Critical patent/WO2008062274A2/en
Publication of WO2008062274A3 publication Critical patent/WO2008062274A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates

Abstract

The novel stable pharmaceutical composition comprising non-steroidal anti inflammatory drug (NSAIDs), as injectables, which provides a clear and stable pharmaceutical composition without incorporation of any additives.
PCT/IB2007/003515 2006-11-20 2007-11-16 Pharmaceutical formulations of nsaids for parentral use WO2008062274A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1904MU2006 2006-11-20
IN1904/MUM/2006 2006-11-20

Publications (2)

Publication Number Publication Date
WO2008062274A2 WO2008062274A2 (en) 2008-05-29
WO2008062274A3 true WO2008062274A3 (en) 2009-04-23

Family

ID=39430108

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/003515 WO2008062274A2 (en) 2006-11-20 2007-11-16 Pharmaceutical formulations of nsaids for parentral use

Country Status (1)

Country Link
WO (1) WO2008062274A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019214715A1 (en) 2018-05-11 2019-11-14 南京清普生物科技有限公司 Meloxicam composition, preparation and preparation method and use thereof
WO2021224815A1 (en) * 2020-05-06 2021-11-11 Cadila Healthcare Limited Stable aqueous parenteral solutions of nonsteroidal anti-inflammatory drug (nsaid)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US20050187212A1 (en) * 2002-09-17 2005-08-25 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceutical composition for topical delivery of meloxicam

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US20050187212A1 (en) * 2002-09-17 2005-08-25 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceutical composition for topical delivery of meloxicam

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ROWE ET AL.: "Handbook of Pharmaceutical Excipients", 2006, pages: 633 - 634 *

Also Published As

Publication number Publication date
WO2008062274A2 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
NO20090175L (en) Stable laquinimod compositions
WO2008008364A3 (en) Enhanced stability phenylephrine liquid compositions
EP2130552A4 (en) Pharmaceutical composition comprising anti-grp78 antibody as active ingredient
WO2009156462A3 (en) Organic compounds
AU2013257508A1 (en) Pharmaceutical compositions
CL2007003265A1 (en) COMPOUNDS DERIVED FROM 1H-PIRAN [2,3-D] PIRIMIDIN-2,4,7-TRIONA; AND PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT OF METABOLIC SYNDROME, DYSLIPIDEMIA AND CARDIOVASCULAR DISEASES BETWEEN OTHERS.
WO2009091576A3 (en) Parenteral formulations of dopamine agonists
UY30319A1 (en) DPP IV INHIBITORS FORMULATIONS
WO2007106746A3 (en) Formulations for ecallantide
DK1808165T3 (en) Dry formulations of aripiprazole
BRPI0819218A2 (en) Methods, kits and compositions for administering pharmaceutical compounds
WO2008013838A3 (en) Pyridizinone derivatives
WO2008051942A3 (en) Farnesoid x receptor agonists
DE602007003074D1 (en) NEW PYRINE DERIVATIVES
WO2008006528A3 (en) Pharmaceutical compositions comprising levetiracetam
DK3851447T3 (en) METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR THE ADMINISTRATION OF 3-AMINO-1-PROPANESULFOUS ACID
NL2000690A1 (en) Stabilized pharmaceutical compositions comprising fesoterodine.
WO2007117556A3 (en) Pharmaceutical compositions and uses thereof
BRPI0719398A2 (en) Pharmaceutical composition.
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
IL195813A0 (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
WO2010021607A3 (en) Pharmaceutical formulation
CL2007001838A1 (en) COMPOUNDS DERIVED FROM 4-OXOQUINOLINE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE PRODUCTION OF AN ANTI-HIV AGENT.
ZA200900237B (en) Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
WO2008092615A3 (en) Herbicidal composition comprising pinoxaden

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07848897

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07848897

Country of ref document: EP

Kind code of ref document: A2